REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Euriprin S.A. (Ecuador)

Main Activities: Offices of Other Health Practitioners
Full name: Euriprin S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Euriprin S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Offices of Other Health Practitioners industry. The enterprise was incorporated on September 17, 2008. 5 (2024) employees currently work for Euriprin S.A.. The latest financial highlights indicate a net sales revenue increase of 3.94% in 2025. Over the same period, its total assets grew by 1.07%. The enterprise’s net profit margin decreased by 19.56% in 2025.

Headquarters
Calle Chimborazo, 117
Guayaquil; Guayas;

Contact Details: Purchase the Euriprin S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Euriprin S.A. report to view the information.
Registered Capital:
Purchase the Euriprin S.A. report to view the information.
Financial Auditors:
Purchase the Euriprin S.A. report to view the information.
Incorporation Date:
September 17, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
25.5%
Purchase this report to view the information.
25.5%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
24.5%
Company Performance
Financial values in the chart are available after Euriprin S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
3.94%▲
Total Operating Revenue
-6.32%▼
Operating Profit
-84.5%▼
EBITDA
-77.68%▼
Net Profit/Loss for the Period
-90.81%▼
Total Assets
1.07%▲
Total Equity
0.7%▲
Operating Profit Margin
-25.8%▼
Net Profit Margin
-19.56%▼
Return on Equity (ROE)
-6.95%▼
Debt / Equity
2.96%▲
Quick Ratio
-0.66%▼
Cash Ratio
-1.38%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo